Quality evaluation of national cancer registry system in Iran: Study protocol

Archives of Iranian Medicine

Volumn 17, Issue 3, 2014, Pages 193-197

  Modirian, Mitra ^a   Rahimzadeh, Shadi ^a,b   Cheraghi, Zahra ^a,c   Khosravi, Ardeshir ^a   Salimzadeh, Hamideh ^d   Kompani, Farzad ^c   Rezaei, Nazila ^a   Qorbani, Mostafa ^a,e,f   Delavari, Alireza ^a   Moradi Lakeh, Maziar ^f   Farzadfar, Farshad ^a,g  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e ALBORZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cancer registry; Iran; Quality assessment

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CONCEPTUAL FRAMEWORK; EVIDENCE BASED PRACTICE; FOLLOW UP; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; IRAN; META ANALYSIS (TOPIC); QUALITATIVE RESEARCH; RISK FACTOR; SYSTEMATIC REVIEW (TOPIC); VALIDITY; CHILD; EPIDEMIOLOGY; INCIDENCE; METHODOLOGY; NEOPLASMS; REGISTER; STANDARDS;

CHILD; EPIDEMIOLOGIC RESEARCH DESIGN; HUMANS; INCIDENCE; IRAN; NEOPLASMS; REGISTRIES; RESEARCH DESIGN;

EID: 84896333545     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Farzadfar F, Delavari A, Malekzadeh R, Mesdaghinia A, Jamshidi HR, Sayyari A, et al. NASBOD 2013: design, definitions, and metrics. Arch Iran Med. 2014; 17(1):7-15.
2. Parkin DM. The evolution of the population-based cancer registry. Nature Reviews Cancer. 2006; 6(8): 603-612.
3. Centers for Disease Control and Prevention, National Program of Cancer Registries (NPCR).
4. Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. European Journal of Cancer. 2009; 45(5): 747-755.
5. Larsen IK, Smastuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, et al. Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness. European Journal of Cancer. 2009; 45(7): 1218-1231.
6. M0ller H, Richards S, Hanchett N, Riaz SP, Luchtenborg M, Holm-berg L, et al. Completeness of case ascertainment and survival time error in English cancer registries: impact on 1-year survival estimates. British Journal of Cancer. 2011; 105(1):170-176.
7. Schouten LJ, Hoppener P, van den Brandt PA, Knottnerus JA, Jager JJ. Completeness of cancer registration in Limburg, The Netherlands. International Journal of.Epidemiology. 1993; 22(3): 369-376.
8. Mattsson B, Wallgren A. Completeness of the Swedish cancer register non-notified cancer cases recorded on death certificates in 1978. Acta Oncologica. 1984; 23(5): 305-313.
9. Brewster DH, Crichton J, Harvey JC, Dawson G. Completeness of case ascertainment in a Scottish regional cancer registry for the year 1992. Public Health. 1997; 111(5): 339-343.
10. Parkin DM, Wabinga H, Nambooze S. Completeness in an African cancer registry. Cancer Causes & Control. 2001; 12(2):147-152.
11. Gajalakshmi V, Swaminathan R, Shanta V. An independent survey to assess completeness of registration: population based cancer registry, Chennai, India. Asian Pac J Cancer Prev. 2001; 2(3):179-183.
12. Nwene U, Smith A. Assessing completeness of cancer registration in the north-western region of England by a method of independent comparison. British Journal of Cancer. 1982; 46(4): 635.
13. Mukherjee AK, Leck I, Langley FA, Ashcroft C. The completeness and accuracy of health authority and cancer registry records according to a study of ovarian neoplasms. Public Health. 1991; 105(1):69-78.
14. Cote TR, O'Brien TR, Ward JW, Wilson SE, Blattner WA. AIDS and cancer registry linkage: measurement and enhancement of registry completeness. Preventive Medicine. 1995; 24(4): 375-377.
15. Ording AG, Nielsson MS, Fr0slev T, Friis S, Garne JP, Sogaard M. Completeness of breast cancer staging in the Danish Cancer Registry, 2004-2009. Clinical epidemiology. 2012; 4: 11.
16. Mallin K, Palis BE, Watroba N, Stewart AK, Walczak D, Singer J, et al. Completeness of American cancer registry treatment data: Implications for quality of care research. J Am Coll Surg. 2013; 216(3): 428-437.
17. Parkin DM, Bray F. Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. European Journal of Cancer. 2009; 45(5): 756-764.
18. Habibi A. Epidemiological aspects of cancer in Iran. Int Surg. 1985; 70: 105-108.
19. Ali Mohagheghi M, Mosavi-Jarrahi A. Review of cancer registration and cancer data in Iran, a historical prospect. Asian Pac J Cancer Prev. 2010;11:1155-1157.
20. Hackl M, Waldhoer T. Estimation of completeness of case ascertainment of Austrian cancer incidence data using the flow method. Eur J Public Health. 2013; 23(5): 889-893
21. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA: A Cancer Journal for Clinicians. 1999; 49(1):33-64.
22. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer. 2010; 127(12): 2893-2917.
23. Shimakawa Y, Bah E, Wild CP, Hall AJ. Evaluation of data quality at the Gambia national cancer registry. International Journal of Cancer. 2013; 132(3): 658-665.
24. Lankarani KB, Khosravizadegan Z, Rezaianzadeh A, Honarvar B, Moghadami M, Faramarzi H, et al. Data coverage of a cancer registry in southern Iran before and after implementation of a population-based reporting system: a 10-year trend study. BMC Health Services Research. 2013; 13(1): 169.
25. Ghojazadeh M, Mohammadi M, Azami-Aghdash S, Sadighi A, Piri R, Naghavi-Behzad M. Estimation of Cancer Cases Using Capture-Recapture Method in Northwest Iran. Asian PacificJournal of Cancer Prevention. 2013; 14(5): 3237-3241.